Kingdon Capital Management’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-15,000
Closed -$2.54M 220
2014
Q2
$2.54M Sell
15,000
-85,000
-85% -$13.2M 0.1% 162
2014
Q1
$12.4M Hold
100,000
0.63% 49
2013
Q4
$11.1M Buy
+100,000
New +$9.55M 0.51% 63
2013
Q3
Sell
-67,000
Closed -$5.64M 266
2013
Q2
$5.64M Buy
+67,000
New +$6.95M 0.33% 91

Other funds holding AGN

Kingdon Capital Management's AGN Position: Q1 2015 in Review

Kingdon Capital Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 198,750 shares — an estimated $42.3M sold.

Kingdon Capital Management first reported a position in AGN in Q1 2014 and held it in 3 quarters. The position peaked at $42.3M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Kingdon Capital Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Kingdon Capital Management sold 198,750 Allergan Inc shares in Q1 2015, an estimated $42.3M.
  • Kingdon Capital Management first reported a position in Allergan Inc in Q1 2014 and held it in 3 quarters.
  • Kingdon Capital Management's Allergan Inc position peaked at $42.3M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Kingdon Capital Management's 13F filing for Q1 2015, filed 15 May 2015.